DGAP-News: Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation
Apricus Biosciences, Inc.
19.10.2011 15:30
—————————————————————————
SAN DIEGO, 2011-10-19 15:30 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that the Korean Patent Office
recently issued a Notice of Allowance to grant a patent for the Company–s
development of a topical cream utilizing vasoactive prostaglandin E to treat
premature ejaculation
